Magnetic resonance proton spectroscopy of the brain in Wilson's disease

Journal of Neurology

Volumn 246, Issue 8, 1999, Pages 693-699

  Kraft, Eduard ^a,b   Trenkwalder, Claudia ^a   Then Bergh, Florian ^a   Auer, Dorothee P ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Proton spectroscopy; Subclinical hepatic encephalopathy; Wilson's disease

Indexed keywords

4 AMINOBUTYRIC ACID; CHOLINE; CREATINE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; LACTIC ACID; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; FEMALE; GRAY MATTER; HEPATIC ENCEPHALOPATHY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PUTAMEN; WHITE MATTER; WILSON DISEASE;

ADOLESCENT; ADULT; BRAIN; ENERGY METABOLISM; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATOLENTICULAR DEGENERATION; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROTONS;

EID: 0032869292     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150050434     Document Type: Article

References (31)

1. 1. Bull PC, Thomas GR, Rommens JM, Forbes JR, Cox DW (1993) The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 5:327-337
2. 2. Butterworth RF (1996) The neurobiology of hepatic encephalopathy. Semin Liver Dis 16:235-244
3. 3. Chamuleau RA, Vogels BA, Bosman DK, Bovee WM (1994) In vivo brain magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) in hepatic encephalopathy. Adv Exp Med Biol 368:23-31
4. 4. Frahm J, Merboldt KD, Hanicke W (1987) Localized proton spectroscopy using stimulated echoes. J Magn Reson 72:502-508
5. 5. Geissler A, Lock G, Frund R, Held P, Hollerbach S, Andus T, Scholmerich J, Feuerbach S, Holstege A (1997) Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging. Hepatology 25:48-54
6. 6. Gitlin N, Lewis DC, Hinkley L (1986) The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis. J Hepatol 3:75-82
7. 7. Horoupian DS, Sternlieb I, Scheinberg ICH (1988) Neuropathological findings in penicillamine-treated patients with Wilson's disease. Clin Neuropathol 7:62-67
8. 8. Jenkins BG, Rosas HD, Chen YC, Makabe T, Myers R, MacDonald M, Rosen BR, Beal MF, Koroshetz W (1998) 1H NMR spectroscopy studies of Huntington's disease: correlations with CAG repeat numbers. Neurology 50:1357-1365
9. 9. Kreis R, Farrow N, Ross BD (1990) Diagnosis of hepatic encephalopathy by proton magnetic resonance spectroscopy. Lancet 336:635-636
10. 10. Kreis R, Farrow N, Ross BD (1991) Localized 1H-NMR spectroscopy in patients with chronic hepatic encephalopathy. Analysis of changes in cerebral glutamine, choline and inositols. NMR Biomed 4:109-116
11. 11. Kreis R, Ross BD, Farrow NA, Ackerman Z (1992) Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 182:19-27
12. 12. Laubenberger J, Haussinger D, Bayer S, Gufler H, Hennig J, Langer M (1997) Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis. Gastroenterology 112:1610-1616
13. 13. Lutsenko S, Cooper MJ (1998) Localization of the Wilson's disease protein product to mitochondria. Proc Natl Acad Sci U S A 95:6004-6009
14. 14. Matthews PM, Andermann F, Silver K, Karpati G, Arnold DL (1993) Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies. Neurology 43:2484-2490
15. 15. McIlwain H, Bachelard HS (1985) Biochemistry and the central nervous system, 5th edn. Churchill-Livingstone, Edinburgh, pp 54-59
16. 16. Medalia A, Isaacs-Glaberman K, Scheinberg IH (1988) Neuropsychological impairment in Wilson's disease. Arch Neurol 45:502-504
17. 17. Michaelis T, Merboldt KD, Hanicke W, Gyngell ML, Bruhn H, Frahm J (1991) On the identification of cerebral metabolites in localized 1H-NMR spectra of human brain in vivo. NMR Biomed 4:90-98
18. 18. Michaelis T, Helms G, Merboldt KD, Hanicke W, Bruhn H, Frahm J (1993) Identification of scyllo-inositol in proton NMR spectra of human brain in vivo. NMR Biomed 6:105-109
19. 19. Provencher SW (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30:672-679
20. 20. Pujol J, Kulisevsky J, Moreno A, Deus J, Alonso J, Balanzo J, Marti-Vilalta JL, Capdevila A (1996) Neurospectroscopic alterations and globus pallidus hyperintensity as related magnetic resonance markers of reversible hepatic encephalopathy. Neurology 47:1526-1530
21. 21. Ross BD, Jacobson S, Villamil F, Korula J, Kreis R, Ernst T, Shonk T, Moats RA (1994) Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities. Radiology 193: 457-463
22. 22. Ross BD, Danielsen ER, Bluml S (1996) Proton magnetic resonance spectroscopy: the new gold standard for diagnosis of clinical and subclinical hepatic encephalopathy? Dig Dis 14 [Suppl 1]:30-39
23. 23. Schapira AH (1998) Inborn and induced defects of mitochondria. Arch Neurol 55:1293-1296
24. 24. Seery JP, Taylor-Robinson SD (1996) The application of magnetic resonance spectroscopy to the study of hepatic encephalopathy. J Hepatol 25:988-998
25. 25. Spreen O, Strauss E (1991) A compendium of neuropsychological tests: norms, and commentary. Oxford University Press, New York
26. 26. Thomas MA, Huda A, Guze B, Curran J, Bugbee M, Fairbanks L, Ke Y, Oshiro T, Martin P, Fawzy F (1998) Cerebral 1H MR spectroscopy and neuropsychologic status of patients with hepatic encephalopathy. AJR Am J Roentgenol 171:1123-1130
27. 27. Thurston JH, Sherman WR, Hauhart RE, Kloepper RF (1989) Myo-inositol: a newly identified nonnitrogenous osmoregulatory molecule in mammalian brain. Pediatr Res 26:482-485
28. 28. Urenjak J, Williams SR, Gadian DG, Noble M (1992) Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J Neurochem 59:55-61
29. 29. Van Den Heuvel AG, Van der Grond J, Van Rooij LG, Van Wassenaer-van Hall HN, Hoogenraad TU, Mali WP (1997) Differentiation between portal-systemic encephalopathy and neurodegenerative disorders in patients with Wilson disease: H-1 MR spectroscopy. Radiology 203:539-543
30. 30. Victor M (1986) Neurologic manifestations of gastrointestinal diseases. In: Asbury AK, McKann CM, Mcdonald WI (eds) Diseases of the nervous system. Clinical neurobiology, Saunders, Philadelphia, pp 1470-1482
31. 31. Walshe JM, Yealland M (1992) Wilson's disease: the problem of delayed diagnosis. J Neurol Neurosurg Psychiatry 55:692-696